Azitra (AZTR) Current Taxes (2024 - 2025)
Azitra (AZTR) reported Current Taxes of $6256.0 for Q4 2025, down 45.94% on a YoY basis from $11572.0 in Q4 2024, and down 45.94% quarter-over-quarter from $11572.0 in Q4 2024.
Azitra (AZTR) Current Taxes (2024 - 2025) Analysis & Trends
Azitra has reported Current Taxes for 2 years, with the latest figure at $6256.0 in Q4 2025.
- For the quarter ending Q4 2025, Current Taxes fell 45.94% year-over-year to $6256.0; the trailing twelve-month figure through Dec 2025 stood at $6256.0 (down 45.94% YoY), and the FY2025 full-year result was $6256.0, down 45.94% from the prior year.
- Current Taxes for Q4 2025 stood at $6256.0, down from $11572.0 in the prior quarter.
- The five-year high for Current Taxes was $11572.0 in Q4 2024, with the low at $6256.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 10,460.56 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Azitra | 20,900.00 | 20,900.00 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6,256.00 |
| Dec 31, 2024 | 11,572.00 |